| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ict-107 | interleukin 13 receptor alpha-2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of brain[MeSHID:D001932] COPPER TOXICOSIS IDIOPATHIC[MeSHID:C565846] Recurrence (disease attribute)[MeSHID:D012008] Glioblastoma[MeSHID:D005909] |
NA | phase 3 | unknown |
| click here to return to the previous page | ||||||||